UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 240

Sortiert nach

Neurobiology of Parkinson's Disease

International journal of molecular sciences, 2023-06, Vol.24 (12), p.9933

2023

Volltextzugriff (PDF)

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease

mSystems, 2020-10, Vol.5 (5)

2020

Volltextzugriff (PDF)

Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

Progress in neurobiology, 2017-08, Vol.155, p.149-170

2017

Volltextzugriff (PDF)

Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia

Journal of Neural Transmission, 2018-08, Vol.125 (8), p.1273-1286

2018

Volltextzugriff (PDF)

Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuse

The international journal of neuropsychopharmacology, 2014-03, Vol.17 (3), p.429-441

2014

Volltextzugriff (PDF)

Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients

Neurobiology of disease, 2023-08, Vol.184, p.106203-106203, Article 106203

2023

Volltextzugriff (PDF)

Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice

Psychopharmacology, 2022-03, Vol.239 (3), p.795-806

2022

Volltextzugriff (PDF)

6‐n‐propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease

Movement disorders, 2018-08, Vol.33 (8), p.1331-1339

2018

Volltextzugriff (PDF)

Mitochondrial Homeostasis and Signaling in Parkinson's Disease

Frontiers in aging neuroscience, 2020-04, Vol.12, p.100

2020

Volltextzugriff (PDF)

Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice

Biomedicine & pharmacotherapy, 2023-05, Vol.161, p.114475-114475, Article 114475

2023

Volltextzugriff (PDF)

Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration

Neurobiology of disease, 2023-08, Vol.184, p.106226-106226, Article 106226

2023

Volltextzugriff (PDF)

MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice

Movement disorders, 2013-12, Vol.28 (14), p.1957-1965

2013

Volltextzugriff (PDF)

Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons’ Degeneration: Link to Parkinson’s Disease

International journal of molecular sciences, 2021-05, Vol.22 (10), p.5326

2021

Volltextzugriff (PDF)

Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease

Frontiers in pharmacology, 2022-08, Vol.13, p.935784-935784

2022

Volltextzugriff (PDF)

La ricerca nei 400 anni dell’Università degli Studi di Cagliari

Morelli, Micaela

2021

Volltextzugriff (PDF)

Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age

International journal of molecular sciences, 2019-03, Vol.20 (7), p.1556

2019

Volltextzugriff (PDF)

Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes

Biomolecules (Basel, Switzerland), 2021-01, Vol.11 (2), p.144

2021

Volltextzugriff (PDF)

Brief history of the medical and non-medical use of amphetamine-like psychostimulants

Experimental neurology, 2021-08, Vol.342, p.113754-113754, Article 113754

2021

Volltextzugriff (PDF)

Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?

Journal of neurochemistry, 2014-11, Vol.131 (3), p.284-289

2014

Volltextzugriff (PDF)

Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease

Synapse (New York, N.Y.), 2007-08, Vol.61 (8), p.606-614

2007

Volltextzugriff (PDF)

Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease

Frontiers in aging neuroscience, 2020-05, Vol.12, p.118-118

2020

Volltextzugriff (PDF)

Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques

PloS one, 2017-07, Vol.12 (7), p.e0181677

2017

Volltextzugriff (PDF)

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences

Frontiers in pharmacology, 2021-08, Vol.12, p.713486-713486

2021

Volltextzugriff (PDF)

D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesia

iScience, 2022-10, Vol.25 (10), p.105263-105263, Article 105263

2022

Volltextzugriff (PDF)

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age

Frontiers in aging neuroscience, 2018-05, Vol.10, p.163-163

2018

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurobiology of Parkinson's Disease

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease

Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia

Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuse

Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients

Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice

6‐n‐propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease

Mitochondrial Homeostasis and Signaling in Parkinson's Disease

Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice

Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration

MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice

Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons’ Degeneration: Link to Parkinson’s Disease

Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease

La ricerca nei 400 anni dell’Università degli Studi di Cagliari

Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age

Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes

Brief history of the medical and non-medical use of amphetamine-like psychostimulants

Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?

Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease

Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease

Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences

D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesia

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age

Suchergebnisse filtern